% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Pignolo:163387,
author = {Pignolo, Loris and Tonin, Paolo and Nicotera, Pierluigi and
Bagetta, Giacinto and Scuteri, Damiana},
title = {{ROBOCOP} ({ROBO}tic {C}are of {P}oststroke {P}ain):
{S}tudy {P}rotocol for a {R}andomized {T}rial to {A}ssess
{R}obot-{A}ssisted {F}unctional and {M}otor {R}ecovery and
{I}mpact on {P}oststroke {P}ain {D}evelopment.},
journal = {Frontiers in neurology},
volume = {13},
issn = {1664-2295},
address = {Lausanne},
publisher = {Frontiers Research Foundation},
reportid = {DZNE-2022-00149},
pages = {813282},
year = {2022},
abstract = {Stroke is one of the most frequent causes of death and
disability worldwide. It is accompanied by the impaired
motor function of the upper extremities in over $69\%$ of
patients up to hemiplegia in the following 5 years in $56\%$
of cases. This condition often is characterized by chronic
poststroke pain, difficult to manage, further worsening
quality of life. Poststroke pain occurs within 3-6 months.
Robot-assisted neurorehabilitation using the Automatic
Recovery Arm Motility Integrated System (ARAMIS) has proven
efficacy in motor function recovery exploiting the movements
and the strength of the unaffected arm. The rationale of the
ROBOCOP (ROBOtic Care of Poststroke pain) randomized trial
is the assessment of the impact of robot-assisted functional
and motor recovery on the prevention of poststroke pain.A
total of 118 patients with hemiplegic arms due to stroke
will be enrolled and randomly allocated with a 1:1 ratio to
ARAMIS or conventional neurorehabilitation group. After a
baseline screening at hospital discharge, ARAMIS or
conventional rehabilitation will be performed for 8 weeks.
The primary endpoint is the prevention of the development of
poststroke pain and the secondary endpoints are prevention
of spasticity and efficacy in clinical motor rehabilitation.
The primary outcome measures consist in the visual analog
scale and the doleur neuropatique 4 and the secondary
outcome measures include: the Modified Ashworth Scale, the
Resistance to Passive movement Scale; the Upper Extremity
Subscale of the Fugl-Meyer Motor Assessment; the Action
Research Arm Test; the Barthel Index for activities of daily
living; and the magnetic resonance imaging (MRI)
recovery-related parameters. After baseline, both primary
and secondary outcome measures will be performed in the
following time points: 1 month after stroke (t 1, half of
the rehabilitation); 2 months after stroke (t 2, after
rehabilitation); and 3 months (t 3) and 6 months (t 4) after
stroke, critical for poststroke pain development.This is the
first clinical trial investigating the efficacy of
robot-assisted neurorehabilitation using ARAMIS on
poststroke pain prevention. This study could remarkably
improve the quality of life of stroke survivors.},
keywords = {ARAMIS (Other) / motor rehabilitation (Other) / post-stroke
pain (Other) / robot-assisted neurorehabilitation (Other) /
stroke recovery (Other)},
cin = {AG Bano / Scientific board},
ddc = {610},
cid = {I:(DE-2719)1013003 / I:(DE-2719)1030000},
pnm = {351 - Brain Function (POF4-351)},
pid = {G:(DE-HGF)POF4-351},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:35250820},
pmc = {pmc:PMC8894665},
doi = {10.3389/fneur.2022.813282},
url = {https://pub.dzne.de/record/163387},
}